A model of filtration and solute transport across the Blood-Brain Barrier Laura Facchini Alberto Bellin Eleuterio F. Toro Mathematics Civil and Environmental Engineering Civil and Environmental Engineering University of Trento (Italy) University of Trento (Italy) University of Trento (Italy) laura.facchini@unitn.it alberto.bellin@unitn.it toro@ing.unitn.it PURPOSE Altered venous hemodynamics affects the transport properties of vessel walls [1], creating microbleed, perivenular iron stores and hypoxia. In the present study, we propose a simple mathematical model for water and solute transport across vessel wall. With the help of suitable analytical and numerical solutions of this model, we investigate the effect of a blood pressure increase on both water flow and molecule transport across the Blood-Brain Barrier (BBB). 1 INTRODUCTION In a typical (peripheral) microvessel, the lumen side of the endothelial cells composing the vessel wall is covered by the glycocalyx, a thin membrane which is believed to exert a sieving effect on macromolecules. Figure 1. Structure of a peripheral blood vessel [modified from http://www.hubrecht.eu/research/dekoning/research.html]. Since the BBB has the role of protecting the Central Nervous System (CNS) from the neurotoxic substances contained in the blood, while nourishing the surrounding brain tissue, it must be highly selective. Indeed, the clefts separating adjacent endothelial cells of the BBB are partially closed by the tight junctions. Furthermore, the microvessels of the CNS are protected externally by the basement membrane and by the astrocyte feet and the pericytes. Figure 2. BBB anatomical structure. Under normal conditions, while macromolecules cross the BBB through transcellular pathways [2], water and small hydrophilic solutes follow paracellular pathways through the clefts separating adjacent endothelial cells [3]. Figure 3. Paracellular and transcellular transport. The breakdown of the BBB with the associated increase of vessel permeability has been observed in traumatic head injury [4], Alzheimer’s disease [5] and it has recently been hypothesised in Multiple Sclerosis ([6], [7]). 2 MATERIALS and METHODS From the conservation of water and solute mass in the steady-state case (following [8]) and after simplifications, we derive the following nonlinear system of ordinary differential equations { (p ′ + rp ′′ ) − σ(π ′ + rπ ′′ )=0, Aπ(π ′ + rπ ′′ )+rπ ′ (Bπ ′ + Cp ′ (1) )=0. Here • r is the distance from the vessel axis, • p = p(r) is the hydrostatic pressure, • π = π(r) is the osmotic pressure, • σ is the reflection coefficient of the wall, • A = l p σ 2 −l d , B = l p σ−l d and C = l p (σ−1) are physiological parameters, • l p is a permeability coefficient, • l d is a diffusion coefficient. Then we calculate P (r) =p(r) − σπ(r), (2) q v (r) =−l p [p ′ (r) − σπ ′ (r)], (3) q s (r) = π(r) ϕRT [Bπ′ (r)+Cp ′ (r)] , (4) where • P (r) is the net pressure, • q v (r) and q s (r) are the volume and solute fluxes per unit length of the vessel, • ϕ is the Stokes radius, • R is the gas constant, • T is the absolute temperature. Now, using the model, we investigate the effect of an increase of blood pressure p c on both water flow and molecule transport across the BBB. Anatomical parameters are obtained from published studies on electron microscopy observations of animal brain or mesenteric vessels. 3 RESULT Figures 4 to 6 show our results in graphical form. Figure 4. Volume flux per unit length of the vessel with respect to the blood pressure p c, with typical venular values of σ and l p (solid curve), and altered values of σ and l p (dashed curve) simulating the glycocalyx/BBB breakdown. Figure 5. Solute flux per unit length of the vessel with respect to the blood pressure p c, with typical venular values of σ and l p (solid curve), and altered values of σ and l p (dashed curve) simulating the glycocalyx/BBB breakdown. Figure 6. Osmotic (π), hydrostatic (p) and net (P ) pressures across the vessel wall, with typical values of venular blood pressure p c (solid curves) and altered values (discontinuous curves), in both cases of lower and higher than normal blood pressure. 4 CONCLUSIONS • Blood pressure increase (hypertension) causes an increase in the volume and solute fluxes per unit length across the vessel wall. • The glycocalyx (and thus BBB) breakdown gives rise to an increase in both fluxes. • We have depicted the osmotic, hydrostatic and net pressures across the vessel wall. • These are very preliminary results and there is some work on more sophisticated model. References [1] Singh A. V. & Zamboni P., J. Cereb. Blood Flow Metab. 29(12), 1867-1878 (2009). [2] Pardridge W. M., Molecular Biotechnology 30(1), 57-69 (2005). [3] Hawkins B. T. & Davis T. P., Pharmacological Reviews 57(2), 173-185 (2005). [4] Fukuda K. et al., Journal of Neurotrauma 12(3), 315-324 (1995). [5] Farkas E. & Luiten P. G. M., Progress in Neurobiology 64(6), 575-611 (2001). [6] Zamboni P. et al., J. Vas. Med. 50(5), 1348-1358 (2009). [7] Tucker T. W., Med. Hypotheses 77(6), 1074-1078 (2011). [8] Katchalsky A. & Curran P.F., Harvard Univ. Press Cambridge MA (1965).
2. Mandato K, Hegener PF, Siskin GP et al. Safety of Endovascular Treatment of CCSVI: A Report of 240 patients with Mutiple Sclerosis. JVIR 2011.E.pub Affiliations: Section of Interventional Radiology, RUSH University Medical Center, Chicago, ILCurrent address for Dr. Ferral: Northshore University Healthsystem, Evanston, IL
- Page 1 and 2:
The 2 nd Annual ISNVD Scientific Me
- Page 3 and 4:
PRINCIPLE CONSIDERATIONS ON VENOUS
- Page 5 and 6:
CHARCOT‘S FIRST POST MORTEM DRAFT
- Page 7 and 8:
SATURDAY - FEBRUARY 18, 2012 2:10pm
- Page 9 and 10:
SATURDAY - FEBRUARY 18, 2012 2:50pm
- Page 11 and 12:
SATURDAY - FEBRUARY 18, 2012 4:00pm
- Page 13 and 14:
SUNDAY - FEBRUARY 19, 2012 8:30am-1
- Page 15 and 16:
SUNDAY - FEBRUARY 19, 2012 11:30am-
- Page 17 and 18:
SUNDAY - FEBRUARY 19, 2012 1:20pm-2
- Page 19 and 20:
SUNDAY - FEBRUARY 19, 2012 3:30pm-4
- Page 21 and 22:
MONDAY - FEBRUARY 20, 2012 8:30am-8
- Page 23 and 24:
MONDAY - FEBRUARY 20, 2012 9:10am-9
- Page 25 and 26:
MONDAY - FEBRUARY 20, 2012 10:50am-
- Page 27 and 28:
MONDAY - FEBRUARY 20, 2012 1:20pm-1
- Page 29 and 30:
using several methods. These method
- Page 31 and 32: TUESDAY - FEBRUARY 21, 2012 8:30am-
- Page 33 and 34: TUESDAY - FEBRUARY 21, 2012 9:20am-
- Page 35 and 36: TUESDAY - FEBRUARY 21, 2012 10:30am
- Page 37 and 38: TUESDAY - FEBRUARY 21, 2012 11:20am
- Page 39 and 40: TUESDAY - FEBRUARY 21, 2012 1:30pm-
- Page 41 and 42: TUESDAY - FEBRUARY 21, 2012 3:30pm-
- Page 43 and 44: TUESDAY - FEBRUARY 21, 2012 4:20pm-
- Page 45 and 46: WEDNESDAY - FEBRUARY 22, 2012 9:10a
- Page 47 and 48: WEDNESDAY - FEBRUARY 22, 2012 10:30
- Page 49 and 50: WEDNESDAY - FEBRUARY 22, 2012 11:10
- Page 51 and 52: WEDNESDAY - FEBRUARY 22, 2012 3:00p
- Page 53 and 54: WEDNESDAY - FEBRUARY 22, 2012 4:00p
- Page 55 and 56: POSTER ABSTRACTS Monday, February 2
- Page 57 and 58: POLITECNICO DI MILANO mlagana@dongn
- Page 60 and 61: Background Iron deposition in clini
- Page 62 and 63: Short-Term Outcomes After Endovascu
- Page 64 and 65: Internal jugular vein valve morphol
- Page 66 and 67: The Cerebral Perfusion of Patients
- Page 68 and 69: Intravascular Ultrasound for detect
- Page 70 and 71: Prevalence of Chronic Cerebrospinal
- Page 72 and 73: Azygos compression and effect of re
- Page 74 and 75: Iron deposition in pediatric multip
- Page 76 and 77: Q Q Q Q Simple mathematical model f
- Page 78 and 79: Introduction Cardiac Effects In The
- Page 80 and 81: Acetazolamide as a medical treatmen
- Page 85 and 86: Physician Documentation of Fluorosc
- Page 87 and 88: Characteristics of patients who mai
- Page 89 and 90: FINDINGS ON VENOGRAPHY IN MS PATIEN
- Page 91 and 92: Does metal-induced hypersensitivity
- Page 93 and 94: GeneralMagneticResonanceImaging(MRI
- Page 95 and 96: Themotivationforthisprotocolofcours
- Page 97 and 98: Magnetic Resonance Imaging (MRI) Tr
- Page 99 and 100: The motivation for this protocol of
- Page 101 and 102: The 2 nd Annual ISNVD Scientific Me
- Page 103 and 104: flow and evidence of increased coll
- Page 105 and 106: Doctors who are using IVUS routinel